🔗 Visit the ClinicalTrials.gov page for NCT00094652
Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma. | J Clin Oncol | 2013 | 5.36 |